137 related articles for article (PubMed ID: 8006409)
21. Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
Coll S; Vila MC; Molina L; Gimenez MD; Guarner C; Solà R
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):347-53. PubMed ID: 15195901
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D
Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973
[TBL] [Abstract][Full Text] [Related]
23. [Aldosterone and renin in liver cirrhosis with ascites].
Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
[TBL] [Abstract][Full Text] [Related]
24. Clinical, biochemical, and hormonal changes after a single, large-volume paracentesis in cirrhosis with ascites.
Gentile S; Angelico M; Bologna E; Capocaccia L
Am J Gastroenterol; 1989 Mar; 84(3):279-84. PubMed ID: 2645767
[TBL] [Abstract][Full Text] [Related]
25. Atrial natriuretic peptide and hemodynamic changes after concentrated ascitic fluid reinfusion in cirrhotic patients.
Messa P; Cannella G; Mioni G; Boscutti G; Messa M; De Biasi F; Cioni A
Nephron; 1993; 65(1):67-72. PubMed ID: 8413794
[TBL] [Abstract][Full Text] [Related]
26. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Gentile S; Bologna E; Terracina D; Angelico M
Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
[TBL] [Abstract][Full Text] [Related]
27. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
Ferrier C; Beretta-Piccoli C; Weidmann P; Gnädinger MP; Shaw S; Suchecka-Rachon K; Saxenhofer H
Am J Nephrol; 1989; 9(4):291-9. PubMed ID: 2530903
[TBL] [Abstract][Full Text] [Related]
28. Large volume abdominal paracentesis effect on some humoral factors and cardiac performance in patients with liver cirrhosis and tense ascities.
El-Ashry N; El-Damarawy M; Salem M; Mogawer S
J Egypt Soc Parasitol; 2007 Aug; 37(2):571-84. PubMed ID: 17985589
[TBL] [Abstract][Full Text] [Related]
29. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
Simón MA; Díez J; Prieto J
Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
[TBL] [Abstract][Full Text] [Related]
30. Fibrinolytic study in plasma and ascitic fluid of cirrhotic patients before and after ascites concentration; reinfusion technique.
Patrassi GM; Martinelli S; Sturniolo GC; Cappellato MG; Vicariotto M; Girolami A
Eur J Clin Invest; 1985 Aug; 15(4):161-5. PubMed ID: 2412833
[TBL] [Abstract][Full Text] [Related]
31. Studies of renin and aldosterone in cirrhotic patients with ascites.
Rosoff L; Zia P; Reynolds T; Horton R
Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
[TBL] [Abstract][Full Text] [Related]
32. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
[TBL] [Abstract][Full Text] [Related]
33. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L
Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365
[TBL] [Abstract][Full Text] [Related]
34. Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
Salmerón JM; Ruiz del Arbol L; Ginès A; García-Pagán JC; Ginès P; Feu F; Claria J; Rivera F; Bosch J; Arroyo V
Hepatology; 1993 May; 17(5):800-6. PubMed ID: 8491447
[TBL] [Abstract][Full Text] [Related]
35. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites.
Titó L; Ginès P; Arroyo V; Planas R; Panés J; Rimola A; Llach J; Humbert P; Badalamenti S; Jiménez W
Gastroenterology; 1990 Jan; 98(1):146-51. PubMed ID: 2293573
[TBL] [Abstract][Full Text] [Related]
36. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Hamdy H; ElBaz AA; Hassan A; Hassanin O
J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
[TBL] [Abstract][Full Text] [Related]
37. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
[TBL] [Abstract][Full Text] [Related]
38. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
[TBL] [Abstract][Full Text] [Related]
39. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.
Sersté T; Francoz C; Durand F; Rautou PE; Melot C; Valla D; Moreau R; Lebrec D
J Hepatol; 2011 Oct; 55(4):794-9. PubMed ID: 21354230
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
